
### [MONDO:0015669](http://purl.obolibrary.org/obo/MONDO_0015669)
**Label:** rare disease with dentinogenesis imperfecta

**Subclasses:** [MONDO:0009804](http://purl.obolibrary.org/obo/MONDO_0009804) (osteogenesis imperfecta type 3), [MONDO:0009806](http://purl.obolibrary.org/obo/MONDO_0009806) (Bruck syndrome 1), [MONDO:0019568](http://purl.obolibrary.org/obo/MONDO_0019568) (Ehlers-Danlos syndrome type 2), [MONDO:0007522](http://purl.obolibrary.org/obo/MONDO_0007522) (Ehlers-Danlos syndrome, classic type), [MONDO:0019567](http://purl.obolibrary.org/obo/MONDO_0019567) (Ehlers-Danlos syndrome type 1), [MONDO:0011670](http://purl.obolibrary.org/obo/MONDO_0011670) (Ehlers-Danlos syndrome due to tenascin-X deficiency), [MONDO:0017195](http://purl.obolibrary.org/obo/MONDO_0017195) (Bruck syndrome), [MONDO:0008148](http://purl.obolibrary.org/obo/MONDO_0008148) (osteogenesis imperfecta type 4), [MONDO:0012217](http://purl.obolibrary.org/obo/MONDO_0012217) (Bruck syndrome 2), 

**Mapped go classes:** [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0000412](http://purl.obolibrary.org/obo/GO_0000412) (histone peptidyl-prolyl isomerization), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0017185](http://purl.obolibrary.org/obo/GO_0017185) (peptidyl-lysine hydroxylation), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0046947](http://purl.obolibrary.org/obo/GO_0046947) (hydroxylysine biosynthetic process), [GO:0008475](http://purl.obolibrary.org/obo/GO_0008475) (procollagen-lysine 5-dioxygenase activity), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0018208](http://purl.obolibrary.org/obo/GO_0018208) (peptidyl-proline modification), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:1903225](http://purl.obolibrary.org/obo/GO_1903225) (negative regulation of endodermal cell differentiation), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0031418](http://purl.obolibrary.org/obo/GO_0031418) (L-ascorbic acid binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005528](http://purl.obolibrary.org/obo/GO_0005528) (FK506 binding), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), 

**Class expressions from DL-Learner:**

- Thing 52.86%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.50%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.50%
- [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer) 52.50%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.86%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.86%


